Axor Biosystems

Axor Biosystems is a Seattle-based life sciences company that has developed the 1Box platform, a revolutionary lab-in-a-microplate system designed to automate and miniaturize biological sample preparation. By utilizing advanced electrical fields rather than mechanical processes, the system integrates biosynthetic reactions, downstream purifications, molecular weight analysis, and quantitation within a single, modular microplate format. This technology enables researchers to process up to 96 samples in parallel with significantly higher resolution and consistency. The system's design eliminates the need for fragmented, multi-instrument workflows, replacing complex setups with a compact, autonomous device that offers interoperability across diverse applications including NGS, synthetic biology, and biomarker detection.

This platform addresses critical bottlenecks in high-throughput data generation, where current methods are often expensive, slow, and labor-intensive. By delivering up to a 100-fold improvement in efficiency, Axor Biosystems provides life science organizations and researchers with a cost-effective solution that reduces turnaround times, capital expenditures, and waste. The 1Box platform is particularly relevant for accelerating breakthroughs in the diagnosis and treatment of complex conditions such as cancer, dementia, and genetic diseases, supporting the increased demand for high-quality biological datasets required by AI and machine learning-driven biology. The company's technology has been recognized in industry competitions, including being named a finalist for the 2025 SLAS Ignite Award.